Judith M. Müller

Judith M. Müller

Auto-generated profile, based on publicly available information

Judith M. Müller

Klinikum der Albert-Ludwigs-Universität Freiburg

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2004
Verified
Journal Article
Closed access
BGBoris Gabriel
Boris Gabriel
SMStephan Mildenberger
Stephan Mildenberger
CWChristian W Weisser
Christian W Weisser
EMEric Metzger
Eric Metzger
GGGerald Gitsch
Gerald Gitsch
JMJudith M Müller
Judith M Müller

15 March 2018 in Development
Verified
Journal Article
Open access
PDF file
DDDelphine Duteil
Delphine Duteil
YTYves Tourrette
Yves Tourrette
AEAdrien Eberlin
Adrien Eberlin
DWDominica Willmann
Dominica Willmann
DPDharmeshkumar Patel
Dharmeshkumar Patel
RSRoland Schüle
Roland Schüle
Nir/ Noc2l is an inhibitor of histone acetyl-transferases (INHAT). In addition to its function on histone acetylation, Nir binds to p53 and TAp63 to regulate their activity. Here, we show that epidermis-specific ablation of Nir impairs epidermal stratification and barrier function, thereby causing perinatal lethality. Nir-deficient epidermis lacks appendages and remains single layered during embryogenesis. Cell proliferation is inhibited, whereas apoptosis and p53 acetylation is increased, indicating that Nir is controlling cell proliferation by limiting p53 acetylation. Transcriptome analysis revealed that Nir regulates expression of essential factors of epidermal development, such as keratins, integrins, and laminins. Furthermore, Nir binds to and controls expression of p63 and limits H3K18ac at the p63 promoter. Corroborating stratification defects, asymmetric cell divisions were virtually absent in Nir-deficient mice, suggesting that Nir is required for correct mitotic spindle orientation. In summary, our data define Nir as a key regulator of skin development.

30 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YJYanhan Jia
Yanhan Jia
SWSheng Wang
Sheng Wang
SUSylvia Urban
Sylvia Urban
JMJudith M. Müller
Judith M. Müller
MSManuela Sum
Manuela Sum
RSRoland Schüle
Roland Schüle
Prostate cancer (PCa) growth depends on de novo lipogenesis controlled by the mitochondrial pyruvate dehydrogenase complex (PDC). In this study, we identify lysine methyltransferase (KMT)9 as a regulator of PDC activity. KMT9 is localized in mitochondria of PCa cells, but not in mitochondria of other tumor cell types. Mitochondrial KMT9 regulates PDC activity by monomethylation of its subunit dihydrolipoamide transacetylase (DLAT) at lysine 596. Depletion of KMT9 compromises PDC activity, de novo lipogenesis, and PCa cell proliferation, both in vitro and in a PCa mouse model. Finally, in human patients, levels of mitochondrial KMT9 and DLAT K596me1 correlate with Gleason grade. Together, we present a mechanism of PDC regulation and an example of a histone methyltransferase with nuclear and mitochondrial functions. The dependency of PCa cells on mitochondrial KMT9 allows to develop therapeutic strategies to selectively fight PCa.

15 August 2025 in Cell Death & Disease
Verified
Journal Article
Open access
HSHans Felix Staehle
Hans Felix Staehle
CKChristoph Koellerer
Christoph Koellerer
ASAnne Marie Staehle
Anne Marie Staehle
JSJana Schulze
Jana Schulze
PEPhilipp Eble
Philipp Eble
JJJonas Jutzi
Jonas Jutzi
The lysine-specific demethylase 1 (LSD1) regulates hematopoietic stem cell differentiation and has been identified as a therapeutic target in hematological disorders. LSD1 demethylates mono and dimethylated histones 3 at lysine 4 and 9. In addition, it acts as a scaffold for the formation of chromatin-modifying complexes that regulates the transcription of myeloid-lineage-specific genes in complex with GFI1, a transcriptional repressor. While both enzymatic and non-enzymatic functions of LSD1 have been well defined, the relative importance of these two functions in hematopoiesis remains incompletely understood. Here, we investigated the contribution of enzymatic and non-enzymatic functions of LSD1 to myelopoiesis. We show that myeloid differentiation is independent of the enzymatic functions of LSD1 but requires the non-enzymatic, scaffolding function, which directs GFI1 binding to target sequences. In the absence of the LSD1 protein, GFI1 DNA binding is diminished, and myeloid cell differentiation arrests at an immature, myelomonocytic-like cell stage, which overexpresses Prtn3. We provide functional data implicating Prtn3 as an effector of the stem cell expansion and myeloid maturation block caused by the loss of LSD1.